Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
6.85M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$8.75M
-
Value change
-
+$1.34M
-
Put/Call ratio
-
0.3
-
Number of buys
-
20
-
Number of sells
-
-9
-
Price
-
$1.28
Significant Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2024
40 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q2 2024.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.85M shares
of 101M outstanding shares and own 6.76% of the company stock.
Largest 10 shareholders include Woodline Partners LP (1.59M shares), MILLENNIUM MANAGEMENT LLC (1.24M shares), VANGUARD GROUP INC (1.03M shares), Schonfeld Strategic Advisors LLC (1.01M shares), Parkman Healthcare Partners LLC (505K shares), SABBY MANAGEMENT, LLC (237K shares), GEODE CAPITAL MANAGEMENT, LLC (236K shares), Colony Group, LLC (161K shares), Polar Asset Management Partners Inc. (155K shares), and UBS Group AG (132K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.